
Key Takeaways
- Everest has signed a global licensing deal for an anti-viral Covid treatment being developed by Singapore’s Experimental Drug Development Centre
- Similar oral anti-viral treatments have been developed by Pfizer and Merck, and are growing in popularity due to their ease of use